Tus kws kho mob
P14-17 Medical Drug Management
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 10, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2611 - 2620 ntawm 4269
Tus kws kho mob
P23-17 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 16, 2017
Tus kws kho mob
P29-17 New Drug-Related Prior Authorization (PA) Criteria: Erythropoietins
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 05, 2017
Tus kws kho mob
P12-17 A New Drug, Pharmaceutical Grade L-Glutamine Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2017
Tus kws kho mob
P28-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P3-17 Added Reimbursement Policies
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2017
Tus kws kho mob
P15-17 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2017
Tus kws kho mob
P34-17 Addition of Drug to the Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide) Prior Authorization Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 13, 2017
Tus kws kho mob
P27-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 24, 2017